Dr. Nimeiri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
251 E Huron St
Chicago, IL 60611Phone+1 312-926-2000Fax+1 312-926-2411
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 2005 - 2008
- Mercy Catholic Medical CenterResidency, Internal Medicine, 2002 - 2005
- University of Khartoum Faculty of MedicineClass of 1992
Certifications & Licensure
- IL State Medical License 2005 - 2026
- PA State Medical License 2002 - 2005
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Vitamin D Supplement in Preventing Colon Cancer in African Americans With Colon Polyps Start of enrollment: 2009 Feb 01
- Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery Start of enrollment: 2009 Aug 01
- Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma Start of enrollment: 2009 Nov 17
- Join now to see all
Publications & Presentations
PubMed
- 32 citationsThe Parity Paradigm: Can Legislation Help Reduce the Cost Burden of Oral Anticancer Medications?Sheetal Mehta Kircher, Caitlin R. Meeker, Halla Sayed Nimeiri, Daniel M. Geynisman, S. Yousuf Zafar
Value in Health. 2016-01-01 - 27 citationsAssessment of Tumor Mutational Burden and Outcomes in Patients With Diverse Advanced Cancers Treated With Immunotherapy.Charu Aggarwal, Rotem Ben-Shachar, Yinjie Gao, Seung Won Hyun, Zachary Rivers
JAMA Network Open. 2023-05-01 - 12 citationsPhase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation ProfilingRobin Kate Kelley, Nancy M. Joseph, Halla Sayed Nimeiri, Jimmy Hwang, Laura Kulik
Liver Cancer. 2021-09-01
Press Mentions
- Tempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advanced Cancer CareNovember 11th, 2024
- Tempus Expands Immuno-Oncology Portfolio with Launch of AI-Enabled, Multimodal Immune Profile Algorithmic TestsJuly 16th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: